Health news
Neoadjuvant chemoradiotherapy improves overall survival (OS), compared with upfront surgery, in patients with resectable or borderline resectable pancreatic cancer, updated data suggest.1 The 5-year OS rate was 14% higher among patients treated with neoadjuvant chemoradiotherapy…
Older patients with advanced pancreatic cancer had better survival if they were prescribed opioids within a year of their cancer diagnosis, according to research published in JCO Oncology Practice. The study included 5770 patients, aged…
The COVID-19 pandemic has not caused patients with pancreatic ductal adenocarcinoma (PDAC) to delay seeking care or prolonged the time to treatment initiation for these patients, according to a study conducted in California. The findings…
An international survey has revealed barriers to accessing cancer drugs deemed essential for routine clinical care. The survey was published in The Lancet Oncology. Researchers surveyed medical oncologists from 82 countries and found that some…
The genomic-adjusted radiation dose (GARD) model can predict outcomes of radiotherapy in patients with cancer, according to results of a study published in The Lancet Oncology. In fact, GARD outperformed radiation dose for predicting time…
Minority populations are underrepresented in clinical trials of pancreatic cancer, and representation has not improved over time, according to research published in Gastroenterology. Researchers evaluated trends in the representation of minority groups in pancreatic cancer…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021